InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Dentzer James E, 董事长兼首席执行官. Director active across 2 companies, notably CURIS INC. In total, 5 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €7k. Activity tracked since 27 January 2022. The latest transaction was filed on 31 July 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Dentzer James E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
6,934 股@ US$1.590.13% mcap16.8% 占其流量Common StockSEC:0001437749-26-025667:0
11,148 股@ US$2.20100.0% 占其流量Common StockSEC:0001437749-26-018549:0
133,333 股Common StockSEC:0001108205-26-000037:0
3,318 股@ US$9.2055.5% 占其流量Common StockSEC:0001437749-25-025102:0
2,406 股@ US$3.18100.0% 占其流量Common StockSEC:0001209191-22-005651:0
5 条申报中的 5 条
About Dentzer James E
Dentzer James E is President & CEO and has 5 filings in total. Across the 5 most recent sampled filings, there were 0 in buys and 6805 in sells, between 2022-01-31 and 2026-08-04. The listed companies are Imunon, Inc. and CURIS INC, and the modal transaction nature is Attribution.
